Press releases

Last day of trading in BTA

24 January, 2022

DexTech Medical AB (“DexTech” or the “Company”) hereby announces that the last day of trading in Paid Subscribed Shares (Sw. BTA) will be on 27 January 2022 and stop day […]


DexTech Medical AB announces outcome of finalized rights issue

27 December, 2021

The subscription period of the rights issue of shares in DexTech Medical AB (“DexTech” or the “Company”), where also the public was able to subscribe for shares, ended on the […]


Today, the subscription period for DexTech Medical AB’s rights issue begins

8 December, 2021

Today, the subscription period begins in DexTech Medical AB’s (“DexTech” or “the Company”) new issue of shares with preferential rights for existing shareholders (the “Rights Issue”). The public is also […]


DexTech announces prospectus due to upcoming rights issue

2 December, 2021

DexTech Medical AB (“DexTech” or “the Company”) hereby publishes a prospectus in connection with the Company’s forthcoming rights issue, the subscription period of which begins on Wednesday, December 8, 2021. […]


Report from the Extraordinary General Meeting in DexTech Medical AB

25 November, 2021

Today, November 25, 2021, an Extraordinary General Meeting of DexTech Medical AB (“DexTech”) was held. The EGM resolved to approve the rights issue decided by the Board on November 8, […]


Report from the Annual General Meeting

25 November, 2021

Today, November 25, 2021, the Annual General Meeting of DexTech Medical AB was held. Below is a summary of the decisions made. All decisions were made by the required majority. […]


Notice of extraordinary general meeting of DexTech Medical AB

8 November, 2021

The shareholders of DexTech Medical AB, org.nr. 556664-6203, is hereby summoned to the Extraordinary General Meeting on Thursday, November 25th, 2021.  The Extraordinary General Meeting begins at 11.30 a.m. in […]


The Board of Directors of DexTech proposes a rights issue of approx. MSEK 58.2 in order to further develop the project with multiple myeloma to clinical research and further verify OsteoDex’s value

8 November, 2021

The Board of Directors of DexTech Medical AB (“DexTech” or the “Company”) has today decided to convene an Extraordinary General Meeting on November 25, 2021, with a proposal for a […]


Invitation to open Annual General Meeting and notice

28 October, 2021

On Thursday, November 25, 2021, DexTech Medical AB (“DexTech”) will hold its Annual General Meeting. Subject to availability, non-shareholders are also welcome to participate without voting rights. At the meeting, […]


Interim report July 1, 2021 – September 30, 2021

22 October, 2021

Summary of the First Quarter (2021-07-01 – 2021-09-30) • Net sales amounted to MSEK 0,0 (0,0) • Operating profit/loss amounted to MSEK -0,9 (-1,5) • Earnings per share* SEK -0,06 […]